IP Library › Assignment 012958/0601
Patent Assignment
Reel/Frame 012958/0601

Merger

Recorded: 2002-06-14 Pages: 19
Assignor
LIPOSOME COMPANY, INC., THE
Executed: 2001-12-28
Assignee
ELAN PHARMACEUTICALS, INC.
800 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties (146)
Liposome Composition for Lupus Assay
Patent: 4,564,599 →
Application: 06/476,495 →
Stable Plurilamellar Vesicles, Their Preparation and Use
Patent: 4,522,803 →
Application: 06/476,496 →
Lipid Vesicles Prepared in a Monophase
Patent: 4,588,578 →
Application: 06/521,176 →
Liposome Composition for Lupus Assay
Patent: 4,668,638 →
Application: 06/535,884 →
Enhancement of Pharmaceutical Activity
Patent: 5,000,958 →
Application: 06/633,481 →
Stable Plurilamellar Vesicles
Patent: 5,030,453 →
Application: 06/660,573 →
Liposome-Gel-Compositions
Patent: 4,708,861 →
Application: 06/695,887 →
Process for Purification of Phospholipids
Patent: 4,714,571 →
Application: 06/698,668 →
Lipid-Dependent Diagnostic Assays
Patent: 4,666,831 →
Application: 06/702,555 →
Steroidal Liposomes
Patent: 4,721,612 →
Application: 06/721,630 →
Dehydrated Liposomes
Patent: 4,880,635 →
Application: 06/759,419 →
Steroidal Liposomes
Patent: 4,891,208 →
Application: 06/773,429 →
Solubilization of Hydrophobic Materials Using Lysophospholipid
Patent: 4,923,854 →
Application: 06/821,366 →
Lipid-Dependent Diagnostic Assays
Patent: 4,698,299 →
Application: 06/831,255 →
Drug Preparations of Reduced Toxicity
Patent: 4,897,384 →
Application: 06/844,248 →
Composition Using Salt Form of Organic Acid Derivative of Alpha- Tocopherol
Patent: 4,861,580 →
Application: 06/911,138 →
Process for Purification of Phospholipids
Patent: 4,814,111 →
Application: 06/928,508 →
Composition for Targeting, Storing and Loading of Liposomes
Patent: 4,885,172 →
Application: 06/941,913 →
Induction of Asymmetry in Vesicles
Patent: 5,204,112 →
Application: 07/061,837 →
Therapeutic Treatment by Intramammary Infusion
Patent: 4,981,692 →
Application: 07/086,467 →
Taste Moderating Composition
Patent: 5,009,819 →
Application: 07/119,667 →
Multilamellar Liposomes Having Improved Trapping Efficiencies
Patent: 4,975,282 →
Application: 07/122,613 →
Spontaneous Vesiculation of Multilamellar Liposomes
Patent: 4,963,297 →
Application: 07/136,267 →
Pharmacological Agent-Lipid Solution Preparation
Patent: 5,154,930 →
Application: 07/160,141 →
Prostaglandin-Lipid Formulations
Patent: 5,082,664 →
Application: 07/195,228 →
Process for Purification of Phospholipids
Patent: 5,084,215 →
Application: 07/260,156 →
Alpha Tocopherol-Based Vesicles
Patent: 5,041,278 →
Application: 07/280,551 →
Encapsulation of Antineoplastic Agents in Liposomes
Patent: 5,077,056 →
Application: 07/284,751 →
Osmotically Dependent Vesicles
Patent: 5,049,392 →
Application: 07/298,470 →
Extrusion Technique for Producing Unilamellar Vesicles
Patent: 5,008,050 →
Application: 07/310,495 →
Novel Emulsions
Patent: 5,171,737 →
Application: 07/318,774 →
Methods and Compositions Using Liposome-Encapsulated Non-Steroidal Anti-Inflammatory Drugs
Patent: 6,759,057 →
Application: 07/323,182 →
Microcrystals Comprising an Active Substance Having an Affinity for Phospholipids, and at Least One Phospholipid, Process of Preparation
Patent: 4,973,465 →
Application: 07/364,481 →
Preparation of Targeted Liposome Systems of a Defined Size Distribution
Patent: 5,059,421 →
Application: 07/370,650 →
Novel Composition for Targeting, Storing and Loading of Liposomes
Patent: 5,047,245 →
Application: 07/399,642 →
Drug Preparations of Reduced Toxicity
Patent: 5,059,591 →
Application: 07/405,623 →
Steroidal Liposomes Exhibiting Enhanced Stability
Patent: 5,100,662 →
Application: 07/422,047 →
Compositions Containing Tris Salt of Cholesterol Hemisuccinate and Antifungal
Patent: 5,231,112 →
Application: 07/425,727 →
Adjuvant Composition
Patent: 5,026,557 →
Application: 07/483,263 →
Potentiation of Immune Responses with Liposomal Adjuvants
Patent: 6,090,406 →
Application: 07/485,388 →
Yellow Color-Formers
Patent: 5,376,451 →
Application: 07/545,551 →
New Process for Preparing Lipid Microparticles
Patent: 5,100,591 →
Application: 07/582,053 →
Method for Preparing Alpha-Tocopheral Vesicles
Patent: 5,234,634 →
Application: 07/599,290 →
Integrity Protected Gelatin
Patent: 5,376,381 →
Application: 07/649,237 →
Stable Plurilamellar Vesicles
Patent: 5,169,637 →
Application: 07/679,569 →
Enzymatic Synthesis of Soluble Phosphatides from Phospholipids
Patent: 5,188,951 →
Application: 07/694,669 →
Novel Composition for Targeting, Storing and Loading of Liposomes
Patent: 5,171,578 →
Application: 07/711,294 →
Lipid Excipient for Nasal Delivery and Topical Application
Patent: 5,200,393 →
Application: 07/758,276 →
Sterodial Liposomes
Patent: 5,288,499 →
Application: 07/758,587 →
Prostaglandin-Lipid Formulations
Patent: 5,262,168 →
Application: 07/821,648 →
Induction of Asymmetry in Vesicles
Patent: 5,252,263 →
Application: 07/854,107 →
Accumulations of Amino Acids and Peptides into Liposomes
Patent: 5,380,531 →
Application: 07/896,509 →
Method for Protein-Liposome Coupling
Patent: 5,399,331 →
Application: 07/946,806 →
Benzoporphyrin Vesicles
Patent: 5,389,378 →
Application: 07/990,923 →
Tocopherol-Based Pharmaceutical Systems
Patent: 5,364,631 →
Application: 08/018,913 →
Method of Dehydrating Liposomes Using Protective Sugars
Patent: 5,578,320 →
Application: 08/022,819 →
Entrapment of Water-Insoluble Compound in Alpha to Copherol-Based Vesicles
Patent: 5,330,689 →
Application: 08/039,941 →
Liposomes Comprising Aminoglycoside Phosphates and Methods of Production and Use
Patent: 5,409,704 →
Application: 08/059,192 →
High Ratio Active Agent: Lipid Complex
Patent: 5,415,867 →
Application: 08/105,764 →
Steroidal Liposomes
Patent: 6,352,716 →
Application: 08/108,822 →
Localized Delivery Using Fibronectin Conjugates
Patent: 5,366,958 →
Application: 08/110,193 →
High Drug:Lipid Formulations of Liposomal Antineoplastic Agents
Patent: 5,616,341 →
Application: 08/112,875 →
Method for Entrapment of Cationic Species in Lemellar Vesicles
Patent: 5,525,232 →
Application: 08/137,371 →
Fusogenic Liposomes and Methods of Making and Using Same
Patent: 5,552,155 →
Application: 08/226,642 →
Reduction of Liposome-Induced Adverse Physiological Reactions
Patent: 5,614,214 →
Application: 08/247,053 →
Method of Producing Liposomes
Patent: 5,540,936 →
Application: 08/253,145 →
Phospholipid Composition and Liposomes Made Therefrom
Patent: 5,429,823 →
Application: 08/303,592 →
Methods of Preparing Interdigitation-Fusion Liposomes and Gels Which Encapsulate a Bioactive Agent
Patent: 5,820,848 →
Application: 08/315,988 →
Therapeutic Use of Multilamellar Liposomal Prostagland
Patent: 5,925,375 →
Application: 08/333,770 →
Methods of Treatment Using Unilamellar Liposomal Arachidonic Acid Metabolite Formulations
Patent: 5,811,118 →
Application: 08/333,975 →
Interdigitation-Fusion Liposomes Containing Arachidonic Acid Metabolites
Patent: 5,882,678 →
Application: 08/339,964 →
Method for Size Separation of Particles
Patent: 5,948,441 →
Application: 08/367,923 →
Treatment Using Arachidonic Acid Metabolite and Particulate Formulations
Patent: 5,840,328 →
Application: 08/371,541 →
Method of Detoxifying Animal Suffering from Overdose.
Patent: 5,622,713 →
Application: 08/375,190 →
Pharmaceutically Active Ceramide-Related Compounds
Patent: 5,631,394 →
Application: 08/383,291 →
Affinity Associated Vaccine
Patent: 5,897,873 →
Application: 08/392,676 →
Methods of Preparing Low-Toxicity Drug-Lipid Complexes
Patent: 6,406,713 →
Application: 08/430,661 →
Low Toxicity Drug-Lipid Systems
Patent: 5,616,334 →
Application: 08/430,699 →
Reduction of Liposome-Induced Adverse Physiological Reactions
Patent: 5,662,930 →
Application: 08/433,665 →
Liposome Continuous Size Reduction Method and Apparatus
Patent: 5,556,580 →
Application: 08/437,906 →
Lipid-Dependent Diagnostic Assays
Patent: 6,261,792 →
Application: 08/441,567 →
Method of Controlling the Size of Liposomes
Patent: 6,596,305 →
Application: 08/442,077 →
Synthetic Lung Surfactant
Patent: 5,614,216 →
Application: 08/442,079 →
Novel Emulsions
Patent: 5,626,873 →
Application: 08/442,080 →
Formulation Preparation Device
Patent: 5,583,052 →
Application: 08/447,660 →
Liposomal Defensins
Patent: 5,766,624 →
Application: 08/449,598 →
Methods of Treatment Using High Drug:Lipid Formulations of Liposomal- Antineoplastic Agents
Patent: 5,744,158 →
Application: 08/450,830 →
Encapsulation of Ionizable Agents in Liposomes
Patent: 5,837,279 →
Application: 08/450,831 →
Peptide-Containing Liposomes, Immunogenic Liposomes and Methods of Preparation and Use
Patent: 5,916,588 →
Application: 08/452,549 →
Phospholipid Composition
Patent: 5,783,210 →
Application: 08/453,132 →
Encapsulation of Antineoplastic Agents in Liposomes
Patent: 5,736,155 →
Application: 08/461,212 →
Method for Loading Lipid Like Vesicles with Drugs or Other Chemicals
Application: 08/472,843 →
Method for Loading Lipid Like Vesicles with Drugs or Other Chemicals
Patent: 5,762,957 →
Application: 08/474,382 →
Hydrophobic Taxane Derivatives
Patent: 5,580,899 →
Application: 08/474,888 →
Taxane-Containing Phosphatidylcholine Liposomes
Patent: 5,683,715 →
Application: 08/482,359 →
Liposomal Ceramide-Related Liposomes and the Therapeutic Use Thereof Thereof
Patent: 5,681,589 →
Application: 08/545,164 →
Methods of Treatment Using Pharmaceutically Active Ceramide-Related Compositions
Patent: 5,677,337 →
Application: 08/547,688 →
Method of Separating Materials from Liposomes or Lipid Complexes
Patent: 5,716,526 →
Application: 08/599,869 →
Multilipid Component Ether Lipid Liposomes
Patent: 5,762,958 →
Application: 08/602,669 →
Treatment Using Prostaglandin and Particulate Formulations
Patent: 6,030,639 →
Application: 08/652,259 →
Detection of Endotoxin Levels in Liposomes, Lipid Bilayers and Lipid Complexes
Patent: 6,015,716 →
Application: 08/679,046 →
Hydrolysis-Promoting Hydrophobic Taxane Derivatives
Patent: 5,703,117 →
Application: 08/712,684 →
Ether Lipid-Containing Pharmaceutical Compositions and Therapeutic Uses Thereof
Patent: 5,932,242 →
Application: 08/720,997 →
Modified Ether Glyceroglycolipids
Patent: 6,153,736 →
Application: 08/722,881 →
Preparation of Liposomal Taxanes
Patent: 6,118,011 →
Application: 08/753,650 →
Novel Synthesis of Myo-Inositol Phosphates
Patent: 5,756,774 →
Application: 08/794,957 →
Liposomal Antineoplastic Agent Compositions
Patent: 5,795,589 →
Application: 08/794,988 →
Liposomal Hydrolysis-Promoting Hydrophobic Taxane Derivatives
Patent: 6,051,600 →
Application: 08/805,184 →
Methods of Dehydrating, Storing and Rehydrating Liposomes
Patent: 5,922,350 →
Application: 08/876,938 →
Pharmaceutical Compositons Containing Interdigitation-Fusion Liposomes and Gels
Patent: 6,086,851 →
Application: 08/881,651 →
Novel Peptide-Lipid Conjugates
Patent: 6,087,325 →
Application: 08/950,618 →
Carrier Containing an Etherlipid/Complementarily Shape Lipid Combination and Therapeutic Uses Thereof
Patent: 6,017,557 →
Application: 08/950,773 →
N-Acyl Phosphatidylethanolamine-Mediated Liposomal Drug Delivery
Patent: 6,120,797 →
Application: 08/951,056 →
Synthesis of Hydrophobic Taxane Derivative
Patent: 5,939,567 →
Application: 08/988,120 →
Etherlipid Containing Multiple Lipid Liposomes
Patent: 5,942,246 →
Application: 09/017,366 →
Preparation of Etherlipid-Containing Multiple Lipid Liposomes
Patent: 6,007,839 →
Application: 09/017,439 →
Etherlipid-Containing Multiple Lipid Liposomes
Patent: 5,965,159 →
Application: 09/017,440 →
High Drug:Lipid Formulations of Liposomal-Antineoplastic Agents
Patent: 6,083,530 →
Application: 09/084,526 →
Liposomal Peptide-Lipid Conjugates and Delivery
Patent: 6,143,716 →
Application: 09/168,010 →
Hydrolysis-Promoting Hydrophobic Taxane Derivatives
Patent: 6,107,332 →
Application: 09/249,004 →
Novel Particulate Formulations
Patent: 6,500,461 →
Application: 09/314,338 →
Publication: US 2002/0034536
Peptide-Lipid Conjugates, Liposomes and Liposomal Drug Delivery
Patent: 6,339,069 →
Application: 09/343,650 →
Etherlipid-Containing Multiple Lipid Liposomes
Patent: 6,180,137 →
Application: 09/390,395 →
Reduction of Liposome-Induced Adverse Physiological Reactions
Application: 09/398,934 →
Liposomal Ceramide-Related Compounds and the Therapeutic Use Thereof
Application: 09/429,694 →
N-ACYL phosphatidylethanolamine-mediated liposomal drug delivery
Patent: 6,294,191 →
Application: 09/487,053 →
D and L Etherlipid Stereoisomers and Liposomes
Patent: 6,667,053 →
Application: 09/540,050 →
Hydrophobic taxane derivatives
Patent: 6,291,690 →
Application: 09/567,366 →
Hydrolysis-promoting hydrophobic taxane derivatives
Patent: 6,392,063 →
Application: 09/618,872 →
Modified Ether Glyceroglycolipids
Patent: 6,573,246 →
Application: 09/644,470 →
Encapsulation of antineoplastic agents in liposomes
Application: 09/715,798 →
Negatively Charged Membrane
Patent: 6,783,937 →
Application: 09/914,165 →
Hydrolysis-Promoting Hydrophobic Taxane Derivatives
Patent: 6,482,850 →
Application: 09/940,672 →
Publication: US 2002/0052518
Etherlipid-Containing Multiple Lipid Liposomes
Patent: 39,042 →
Application: 09/976,936 →
Liposome Extrusion Process
Patent: 6,623,671 →
Application: 09/988,665 →
Publication: US 2002/0050660
C-Glucosyl Ether Lipids
Patent: 6,613,748 →
Application: 10/011,781 →
Publication: US 2002/0128214
Solid phase assay
Application: 10/088,796 →
Low toxicity drug-lipid systems
Application: 10/132,151 →
Publication: US 2002/0119170
Modular targeted liposomal delivery system
Application: 60/209,088 →
Enantiomers of unsaturated alkyllysophosphonocholines and use as antineoplastics
Application: 60/270,308 →
Efficient liposomal encapsulation
Application: 60/343,166 →
Efficient liposomal encapsulation under mild conditions
Application: 60/343,211 →
Efficient nucleic acid encapsulation into medium sized liposomes
Application: 60/343,251 →
Efficient nucleic acid encapsulation into medium sized-liposomes
Application: 60/346,284 →
Efficient liposomal encapsulation under mild conditions
Application: 60/346,285 →
Efficient liposomal encapsulation
Application: 60/346,287 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest. Mar 24, 1983
From: JANOFF, ANDREW S.; OSTRO, MARC J.; WEINER, ALAN L.; WEISSMANN, GERALD
To: LIPOSOME CO., INC., THE, A CORP. OF DE
Reel/Frame 004108/0610 →
Assignment of Assignors Interest. Mar 24, 1983
From: LENK, ROBERT P.; FOUNTAIN, MICHAEL W.; JANOFF, ANDREW S.; OSTRO, MARC J.
To: LIPOSOME CO., INC., THE
Reel/Frame 004139/0975 →
Assignment of Assignors Interest. Aug 8, 1983
From: FOUNTAIN, MICHAEL W.; WEISS, STEVEN J.; POPESCU, MIRCEA C.
To: LIPOSOME COMPANY, INC, THE, A DE CORP.
Reel/Frame 004168/0553 →
To Correct the Name of the Assignee Recorded March 24, 1983 at Reel 4139, Frames 975-977, Assignor Does Hereby Cofirms the Assignment of the Entire Interest. (See Record for Details) Aug 12, 1983
From: LENK, ROBERT P.; FOUNTAIN, MICHAEL W.; JANOFF, ANDREW S.; OSTRO, MARC J.
To: LIPOSOME COMPANY, INC., THE
Reel/Frame 004156/0788 →
To Correct the Name of the Assignee Recorded March 24, 1983 at Reel 4108, Frames 610-612 Assignor Does Hereby Confirms the Assignment of the Entire Interest( Negative Certificate Attached). Sep 22, 1983
From: JANOFF, ANDREW S.; OSTRO, MARC J.; WEINER, ALAN L.; WEISSMANN, GERALD
To: LIPOSOME COMPANY, INC., THE
Reel/Frame 004172/0607 →
Assignment of Assignors Interest. Apr 11, 1984
From: JANOFF, ANDREW S.; OSTRO, MARC J.; WEINER, ALAN L.; WEISSMANN, GERALD
To: LIPOSOME COMPANY, INC., THE, ONE RESEARCH WAY, PRINCETON FORRESTAL CENTER, PRINCETON, 08540 A CORP.
Reel/Frame 004268/0765 →
Assignment of Assignors Interest. Jul 26, 1984
From: FOUNTAIN, MICHAEL W.; WEISS, STEVEN J.; LENK, ROBERT P.; POPESCU, MIRCEA C.
To: LIPOSOME COMPANY, INC., THE
Reel/Frame 004343/0084 →
Assignment of Assignors Interest. Dec 12, 1984
From: LENK, ROBERT P.; FOUNTAIN, MICHAEL W.; JANOFF, ANDREW S.; POPESCU, MIRCEA C.
To: LIPOSOME COMPANY, INC., THE
Reel/Frame 004354/0039 →
Assignment of Assignors Interest. Feb 6, 1985
From: TREMBLAY, PAUL A.; KEARNS, JOHN J.
To: LIPOSOME COMPANY, INC., THE, A CORP OF DEL
Reel/Frame 004366/0956 →
Assignment of Assignors Interest. Apr 10, 1985
From: JANOFF, ANDREW S.; POPESCU, MIRCEA C.; WEINER, ALAN L.; BOLCSAK, LOIS E.
To: LIPOSOME COMPANY, INC., THE, A CORP OF DE.
Reel/Frame 004414/0724 →
Assignment of Assignors Interest. Sep 10, 1985
From: JANOFF, ANDREW S.; POPESCU, MIRCEA C.; WEINER, ALAN L.; BOLSCAK, LOIS E.
To: LIPOSOME COMPANY, INC. THE, A CORP OF DE.
Reel/Frame 004454/0173 →
Assignment of Assignors Interest. Oct 10, 1985
From: POPESCU, MIRCEA C.; WEINER, ALAN L.; CARPENTER-GREEN, SHARON S.
To: LIPOSOME COMPANY, INC., THE, ONE RESEARCH WAY, PRINCETON FORRESTAL CENTER, PRINCETON, NJ., A CORP. OF DE.
Reel/Frame 004465/0699 →
Assignment of Assignors Interest. Jan 11, 1986
From: UNIVERSITY OF BRITISH COLUMBIA
To: LIPOSOME COMPANY, INC., THE,
Reel/Frame 004496/0424 →
Assignment of Assignors Interest. Mar 12, 1986
From: TILCOCK, COLIN P. S.; CULLIS, PIETER R.; HOPE, MICHAEL J.; JANOFF, ANDREW S.
To: LIPOSOME COMPANY, INC., THE
Reel/Frame 004552/0402 →
Assignment of Assignors Interest. Apr 3, 1986
From: JANOFF, ANDREW S.; RAUCH, JOYCE; TILCOCK, COLIN P. S.
To: LIPOSOME COMPANY, INC., THE, A CORP OF DE.
Reel/Frame 004527/0425 →
Assignment of Assignors Interest. Apr 24, 1986
From: JANOFF, ANDREW S.; RAUCH, JOYCE; TILCOCK, COLIN P. S.
To: LIPOSOME COMPANY, INC. THE, A CORP OF DELAWARE
Reel/Frame 004543/0068 →
Assignment of Assignors Interest. May 12, 1986
From: MONTREAL GENERAL HOSPITAL REAEARCH INSTITUTE THE
To: LIPOSOME COMPANY, INC. THE
Reel/Frame 004554/0849 →
Assignment of Assignors Interest. Sep 24, 1986
From: JANOFF, ANDREW S.; BOLCSAK, LOIS E.; WEINER, ALAN L.; TREMBLAY, PAUL A.
To: LIPOSOME COMPANY, INC. THE
Reel/Frame 004620/0874 →
Assignment of 1/2 of Assignors Interest Nov 7, 1986
From: LIPOSOME COMPANY, INC., THE, (A DE CORP.)
To: AIR PRODUCTS AND CHEMICALS, INC., A CORP. OF DE
Reel/Frame 004843/0610 →
Assignment of Assignors Interest. Nov 7, 1986
From: KEARNS, JOHN J.; TREMBLAY, PAUL A.
To: LIPOSOME COMPANY, INC., THE, ONE RESEARCH WAY, PRINCETON FORRESTAL CENTER, PRINCETON, NEW JERSEY 08540, A CORP. OF DE.
Reel/Frame 004812/0191 →
Assignment of Assignors Interest. Nov 7, 1986
From: ROBEY, RAYMOND J.; SUNDER, SWAMINATHAN
To: AIR PRODUCTS AND CHEMICALS, INC., P.O. BOX 538, ALLENTOWN, PA. 18105, A CORP. OF DE.
Reel/Frame 004812/0189 →
Assignment of Assignors Interest. Nov 12, 1986
From: UNIVERSITY OF BRITISH COLUMBIA, THE
To: LIPOSOME COMPANY, INC., THE, ONE RESEARCH WAY, PRINCETON FORRESTAL CENTER, PRINCENTON, NEW JERSEY 08540, A CORP. OF DE.
Reel/Frame 004630/0603 →
Assignment of Assignors Interest. Nov 12, 1986
From: UNIVERSITY OF BRITISH COLUMBIA, THE
To: LIPOSOME COMPANY, INC., THE, ONE RESEARCH WAY, PRINCETON FORRESTAL CENTER, PRINCETON, NEW JERSEY, 08540, A CORP. OF DE.
Reel/Frame 004630/0117 →
Assignment of Assignors Interest. Nov 12, 1986
From: UNIVERSITY OF BRITISH COLUMBIA, THE
To: LIPOSOME COMPANY, INC., THE
Reel/Frame 004630/0120 →
Assignment of Assignors Interest. Feb 24, 1987
From: BALLY, MARCEL B.; LOUGHREY, HELEN; CULLIS, PIETER R.
To: LIPSOME COMPANY, INC., THE
Reel/Frame 004693/0485 →